Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/41833

Title:	Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project.
Authors:	Pose, Antonio Almenar, Luis Gavira, Juan José López-Granados, Amador Blasco, Teresa Delgado, Juan Aramburu, Oscar Rodríguez, Avelino Manzano, Luis Manito, Nicolás View more
Keywords:	Congestive heart failure Diuresis Hyponatraemia Tolvaptan Vasopressin type 2 receptors View more
Issue Date:	May-2017
Citation:	ESC Heart Fail.2017 May;(4)2:130-137
Abstract:	Hyponatraemia is an electrolyte disorder that occurs in advanced congestive heart failure (HF) and worsens prognosis. We explored the usefulness of tolvaptan, which has shown promising results in the treatment of this condition.
PMID:	28451449
URI:	https://hdl.handle.net/20.500.12530/41833
Rights:	openAccess
ISSN:	2055-5822
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. 12 de Octubre > Artículos

Files in This Item:

File	Description	Size	Format
PMC5396041.pdf		190.43 kB	Adobe PDF	View/Open